Withdrawal of German Nullification Action
10 June 2009
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) advises that the nullification action filed in the German Federal Patent Court against German Patent No. 69029018.7 by Bioscientia Institut fuer Medizinische Diagnostik GmbH (“Bioscientia”) of Ingelheim, Germany has been withdrawn by Bioscientia, with the approval of the Court.  Bioscientia has no right of appeal.

German Patent No. 69029018.7 is owned by Genetic Technologies Limited and is part of the Company’s worldwide family of patents covering so-called “non-coding DNA”.  These patents form the basis of the Company’s out-licensing program.  While the Company believes this is a positive outcome, the action related only to the German part of a European patent, a jurisdiction that has not historically been a significant source of licensing revenue for Genetic Technologies Limited.

_________________________________________________________________________________

FOR FURTHER INFORMATION PLEASE CONTACT

Dr. Paul D.R. MacLeman
Chief Executive Officer
Genetic Technologies Limited
Phone: +61 3 8412 7000